Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast-Reference-Cited by-同舟云学术

Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast

Published:2010-08-12 Issue:5 Volume:86 Page:345-350
ISSN:1052-0295
Container-title:Biotechnic & Histochemistry
language:en
Short-container-title:Biotechnic & Histochemistry

Author:

Lin Y,Hatem J,Wang J,Quinn A,Hicks DG,Tang P

Publisher

Informa UK Limited

Subject

Medical Laboratory Technology,Histology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10520295.2010.502845

Reference28 articles.

1. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

2. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studies

3. Molecular Classification of Breast Carcinomas Using Tissue Microarrays

4. Validation of Tissue Microarray Technology in Breast Carcinoma

5. Intratumor heterogeneity of biomarker expression in breast carcinomas

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of Amine Oxidase Proteins in Adrenal Cortical Neoplasm and Pheochromocytoma;Biomedicines;2023-07-04

2. Intratumor Heterogeneity of Synchronous In Situ and Invasive Breast Carcinoma Revealed Using Multi-region Exome Sequencing;Anticancer Research;2021-07-19

3. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review;Nuclear Medicine and Biology;2021-01

4. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update;Journal of Clinical Oncology;2020-04-20

5. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update;Archives of Pathology & Laboratory Medicine;2020-01-13